Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Pellicano

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer Discovery|September 16, 2016
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T Scott, Koorosh Korfi, Peter Saffrey, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 20, 2025
Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi ConsensusMatteo Bruglia, Francesca Cardini, Raffaella Di Luzio, et al.
Blood|May 26, 2016
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cellsAmy Sinclair, Laura Park, Mansi Shah, et al.
Blood|February 14, 2018
<i>hsa-mir183/EGR1</i>-mediated regulation of E2F1 is required for CML stem/progenitor cell survivalFrancesca Pellicano, Laura Park, Lisa E M Hopcroft, et al.
Nature|June 10, 2016
Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cellsSheela A Abraham, Lisa E M Hopcroft, Emma Carrick, et al.
Leukemia|September 26, 2021
Spred1 deficit promotes treatment resistance and transformation of chronic phase CMLJunjing Qiao, Chen Liang, Dandan Zhao, et al.
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Journal of Medicinal Chemistry|March 31, 2025
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of RasCharles W Parry, Francesca Pellicano, Alexander W Schüttelkopf, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer Discovery|September 16, 2016
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T Scott, Koorosh Korfi, Peter Saffrey, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 20, 2025
Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi ConsensusMatteo Bruglia, Francesca Cardini, Raffaella Di Luzio, et al.
Blood|May 26, 2016
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cellsAmy Sinclair, Laura Park, Mansi Shah, et al.
Blood|February 14, 2018
<i>hsa-mir183/EGR1</i>-mediated regulation of E2F1 is required for CML stem/progenitor cell survivalFrancesca Pellicano, Laura Park, Lisa E M Hopcroft, et al.
Nature|June 10, 2016
Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cellsSheela A Abraham, Lisa E M Hopcroft, Emma Carrick, et al.
Leukemia|September 26, 2021
Spred1 deficit promotes treatment resistance and transformation of chronic phase CMLJunjing Qiao, Chen Liang, Dandan Zhao, et al.
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Journal of Medicinal Chemistry|March 31, 2025
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of RasCharles W Parry, Francesca Pellicano, Alexander W Schüttelkopf, et al.
Pageof 3